Publication:
Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer

Simple item page
dc.contributor.authorNongnuch Sirachainanen_US
dc.contributor.authorAmpaiwan Chuansumriten_US
dc.contributor.authorSurapan Parapakpenjuneen_US
dc.contributor.authorPakawan Wongwerawattanakoonen_US
dc.contributor.authorSurapong Lertthammakiaten_US
dc.contributor.authorPraguywan Kadegasemen_US
dc.contributor.authorWerasak Sasanakulen_US
dc.contributor.otherFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherMaharaj Nakhon Ratchasima Hospitalen_US
dc.date.accessioned2022-08-04T09:14:47Z
dc.date.available2022-08-04T09:14:47Z
dc.date.issued2021-09-01en_US
dc.identifier.citationPediatric Blood and Cancer. Vol.68, No.9 (2021)en_US
dc.identifier.doi10.1002/pbc.29111en_US
dc.identifier.issn15455017en_US
dc.identifier.issn15455009en_US
dc.identifier.other2-s2.0-85105949183en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/77926
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105949183&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleBenefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titeren_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105949183&origin=inwarden_US

Files

Collections

Scopus 2021